ℹ️
🇬🇧
Search
Search for people relevant for "Antibodies"
Antibodies
Person
Class
Person
Publication
Programmes
MUDr. Dana Ďuricová Ph.D.
Academic staff at First Faculty of Medicine
119 publications
Publications
publication
PHOSPHATIDYLSERINE-DEPENDENT ANTI-PROTHROMBIN (APS/PT) ANTIBODIES AND ANTIPHOSPHOLIPID (APL) ANTIBODIES IN ANTI-TNF-ALPHA ANTIBODY-TREATED PATIENTS WITH INFLAMMATORY BOWEL DISEASES (IBD)
Publication without faculty affiliation
publication
Anti-infliximab antibodies in routine clinical practice - is it worth to assess them?
Publication without faculty affiliation
publication
Tofacitinib in pregnancy: Assessing Pregnancy and Infant Outcomes, Cord Blood and Breast Milk Concentrations
2024 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?
2023 |
First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
publication
News in gastroenterology, hepatology and digestive endoscopy
2023 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Recommendations of the Working Group for IBD for the Diagnosis and Drug Treatment of Ulcerative Colitis
2022 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Third Faculty of Medicine
publication
Safety of vedolizumab and ustekinumab in the treatment of pregnant women with inflammatory bowel disease - a multicentre retrospective-prospective observational study
2022 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Central Library of Charles University
publication
Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study
2022 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Central Library of Charles University
publication
Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study
2022 |
Faculty of Physical Education and Sport, First Faculty of Medicine, Second Faculty of Medicine
publication
Cellular and humoral immune responses to SARS-CoV-2 vaccination in inflammatory bowel disease patients
2022 |
First Faculty of Medicine, Second Faculty of Medicine
Load more publications (109)
Loading network view...